Suppr超能文献

[用血凝试验检测可溶性纤维蛋白复合物。临床应用(作者译)]

[The detection of soluble fibrin complexes by a haemagglutination test. Clinical applications (author's transl)].

作者信息

Soria J, Soria C, de Rodriguez S, Horellou M H, Samama M, Bilski-Pasquier G

出版信息

Nouv Presse Med. 1977 Dec 17;6(43):4045-8.

PMID:600751
Abstract

Testing for soluble fibrin complexes was performed using a sensitive and reliable haemagglutination assay, with red cells sensitized by fibrin monomers. The principle is based on the fact that the monomers linked to red cells and induce their agglutination. This test, used in clinical trials, has revealed the presence of soluble complexes in every confirmed case of acute DIC, but also in Chronic DIC where diagnosis is difficult to establish (negative ethanol gelation test, normal or sub-normal levels of fibrin breakdown products). In Cirrhosis of the liver, the test gives positive results in a non negligible number of cases. Several hypotheses are made to explain why in certain confirmed cases of DIC, low fibrin breakdown products levels are found.

摘要

采用一种灵敏可靠的血凝试验检测可溶性纤维蛋白复合物,该试验用纤维蛋白单体致敏红细胞。其原理基于与红细胞相连的单体可诱导红细胞凝集这一事实。此试验用于临床试验,结果显示在每例确诊的急性弥散性血管内凝血(DIC)病例中均存在可溶性复合物,在诊断困难的慢性DIC病例(乙醇凝胶试验阴性、纤维蛋白降解产物水平正常或低于正常)中也有发现。在肝硬化患者中,该试验在相当数量的病例中呈阳性结果。针对为何在某些确诊的DIC病例中纤维蛋白降解产物水平较低,提出了几种假说。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验